FDA Tells Congress it is Mulling Strategies to Regulate DTC Genetic Tests as Medical Devices

At a congressional hearing on DTC genomics this week, an FDA official acknowledged that the agency had waited too long to regulate this rapidly growing field. The agency said it is considering an "out-of-the-box approach" toward overseeing the consumer genomics industry.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.